Meta-analysis of 14 RCTs (n=643) of psychedelics for psychiatric disorders: treatment beat control for depressive (SMD -0.82), PTSD (SMD -0.89) and anxiety (SMD -0.66) symptoms, but control groups also improved substantially from baseline.
Meta-analysisn = 643
Meshkat et al. Magnitude of response in treatment and control groups within psychedelic trials for psychiatric disorders: A meta-analysis